TrialAlimentary pharmacology & therapeutics2015

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects.

H Jenkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.